RG9MTD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.622800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.207800E-01
Normal-vs-Stage2
4.525600E-01
Normal-vs-Stage3
1.750190E-01
Normal-vs-Stage4
5.986200E-01
Stage1-vs-Stage2
9.542300E-03
Stage1-vs-Stage3
9.685700E-02
Stage1-vs-Stage4
9.998800E-01
Stage2-vs-Stage3
3.420000E-01
Stage2-vs-Stage4
3.282200E-01
Stage3-vs-Stage4
1.648840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.777200E-01
Normal-vs-AfricanAmerican
3.301600E-01
Normal-vs-Asian
7.085000E-01
Caucasian-vs-AfricanAmerican
5.381200E-01
Caucasian-vs-Asian
9.580600E-01
AfricanAmerican-vs-Asian
7.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.103400E-01
Normal-vs-Female
8.585800E-01
Male-vs-Female
8.371900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.157000E-01
Normal-vs-Age(41-60Yrs)
9.124600E-01
Normal-vs-Age(61-80Yrs)
5.014800E-01
Normal-vs-Age(81-100Yrs)
7.695000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.950200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.019800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.616800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.140350E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.240600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.873000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.699400E-01
Normal-vs-Daily Drinker
6.457200E-01
Normal-vs-Weekly Drinker
3.819400E-01
Normal-vs-Occasional Drinker
5.724800E-01
Normal-vs-Social Drinker
8.987400E-01
Non Drinker-vs-Daily Drinker
7.214800E-01
Non Drinker-vs-Weekly Drinker
8.079400E-01
Non Drinker-vs-Occasional Drinker
3.293200E-01
Non Drinker-vs-Social Drinker
2.130000E-01
Daily Drinker-vs-Weekly Drinker
8.736800E-01
Daily Drinker-vs-Occasional Drinker
7.638600E-01
Daily Drinker-vs-Social Drinker
3.273000E-01
Weekly Drinker-vs-Occasional Drinker
5.601400E-01
Weekly Drinker-vs-Social Drinker
2.754400E-01
Occasional Drinker-vs-Social Drinker
4.200200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.541200E-01
Normal-vs-Grade 2
5.444300E-02
Normal-vs-Grade 3
8.815900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.596000E-01
Grade 1-vs-Grade 3
2.129200E-01
Grade 1-vs-Grade 4
2.541200E-01
Grade 2-vs-Grade 3
7.724600E-01
Grade 2-vs-Grade 4
5.444300E-02
Grade 3-vs-Grade 4
8.815900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.780200E-01
Normal-vs-NonDiabetic
7.277200E-01
Diabetic-vs-NonDiabetic
8.498000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.396250E-01
Normal-vs-NoPancreatitis
6.255600E-01
Pancreatitis-vs-NoPancreatitis
1.364410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.102400E-01
Normal-vs-N1
4.734600E-01
N0-vs-N1
2.707200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.906800E-01
Normal-vs-TP53-NonMutant
9.041000E-01
TP53-Mutant-vs-TP53-NonMutant
1.324840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
